Wayne, Pennsylvania, April 02, 2011 – Pierrel Research USA, Inc., the US subsidiary of Pierrel Research International AG, announced today that Linda Nardone, Ph.D., RAC, has joined the organization as a Regulatory Affairs Director.Dr. Nardone has widespread experience in Regulatory Affairs having worked for 28 years in the pharmaceutical, biotechnology, and medical device industries. Her vast expertise in critical areas includes oncology, diagnostic imaging, anti-infectives, dermatology, rheumatology, pain,gastroenology, cardiology, respiratory, endocrinology, biodefense, and vaccines. She also has documented success coordinating drug and biologics development, such as Omnipaque®, Omniscan®,Bexxar®, and Protonix®.
“Linda is a great asset to the company.” said Michael Laird, CEO of Pierrel Research USA, Inc.
“Her strategic advice and support for Business Development is a key priority for Pierrel. The experience she has gained in Regulatory Affairs includes numerous FDA submissions and approvals relating to generic and proprietary drugs.”
Dr. Nardone received her Ph.D. in Physiology from Pennsylvania State University and her B.S, in Science, from Fairleigh Dickinson University. She also obtained Regulatory Affairs Certification through the Regulatory Affairs Professional Society Examination. In addition, Dr. Nardone is the Editor/Author of the first edition of a highly regarded book entitled Fundamentals of Regulatory Affairs.
About Pierrel Research International AG:
Pierrel Research International AG is a global contract research organization which operates both in Europe and the USA, providing consultancies and full services for research and development of new molecules and drug products. It is a whollyowned subsidiary of Pierrel S.p.A. Pierrel S.p.A., a global provider to the pharmaceutical and life science industries, specializes in Research and development(Contract Research) and production (Contract Manufacturing) of drug products, and is listed on the Italian Stock Exchange. The Pierrel Group enjoys more than 50 years of experience in the pharmaceutical sector and is one of the main European manufacturers of dental anesthetic drug products. The manufacturing facility in Capua, Italy, near Naples, has been authorized by the FDA for the production of sterile small volumes parenteral drugs.Pierrel Research USA, Inc. is located in Wayne, Pennsylvania.
For further information: Business Development Gary Goldberg at g.goldberg@pierrelgroup.com Tel. 610-975-9533 Pierrel S.p.A Corporate office is located in Milan, Italy.
For further information: Pierrel S.p.A. Investor Relations Dott. Aurelio Matrone Email: investor.relations@pierrelgroup.com tel. +39 02 2413491 fax +39 02 24134201 Image Building Simona Raffaelli, Emanuela Borromeo, Camilla Castaldo Tel. 02/8901.1300 E-mail: pierrel@imagebuilding.it
